DOXEPIN ISOMERS AND ISOMERIC MIXTURES AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS
The invention relates to use of the cis-(Z) isomer or isomeric mixtures containing specified ratios of the cis-(Z) and trans-(E) isomers of doxepin, metabolites of doxepin, pharmaceutically-acceptable salts of doxepin and prodrugs of the same; compositions containing the same, for the treatment of sleep disorders
1 . A method for the treatment of a patient suffering from insomnia comprising administering to said patient doxepin, a pharmaceutically-acceptable salt or a prodrug thereof in a daily dosage ranging from about 0.0001 to about 499 milligrams, wherein the doxepin, the salt or the prodrug is a geometric isomer mixture containing about 18.2% to about 100.0% of the cis-(Z) isomer or is 100% cis-(Z) isomer.
2 . The method of claim 1 , wherein said geometric isomer mixture contains more than 20% of the cis-(Z) isomer.
3 . The method of claim 1 , wherein said geometric isomer mixture contains more than 50% of the cis-(Z) isomer.
4 . The method of claim 1 , wherein said geometric isomer mixture contains more than 90% of the cis-(Z) isomer.
5 . The method of claim 1 , wherein said geometric isomer mixture contains more than 95% of the cis-(Z) isomer.
6 - 7 . (canceled)
8 . The method of claim 1 , wherein said geometric isomer mixture contains about 20% to about 99.9% of the cis-(Z) isomer.
9 - 20 . (canceled)
21 . The method of claim 1 , wherein the daily dosage is about 0.01 to about 20 milligrams.
22 - 31 . (canceled)
32 . A composition comprising a pharmaceutically-acceptable carrier and doxepin, a pharmaceutically-acceptable salt of doxepin, or a prodrug of doxepin in a unit dosage form of about 0.0001 milligrams to about 499 milligrams, wherein the doxepin, the salt or the prodrug is a geometric isomer mixture containing about 18.2% to about 100.0% of the cis-(Z) isomer or is 100% cis-(Z) isomer.
33 - 38 . (canceled)
39 . The composition of claim 32 , wherein said geometric isomer mixture contains about 20% to about 99.9% of the cis-(Z) isomer.
40 - 50 . (canceled)
51 . The composition of claim 32 , wherein the unit dosage form is about 0.1 to about 20 milligrams.
52 - 58 . (canceled)
59 . A method for treating insomnia comprising administering to a patient a metabolite of doxepin, a pharmaceutically-acceptable salt thereof, or a prodrug thereof in a daily dosage ranging from about 0.0001 to about 499 milligrams, wherein the metabolite of doxepin, the salt or the prodrug is a geometric isomer mixture containing about 18.2% to about 100.0% of the cis-(Z) isomer or is 100% cis-(Z) isomer.
60 - 87 . (canceled)
88 . A composition comprising a pharmaceutically-acceptable carrier and a metabolite of doxepin, a pharmaceutically-acceptable salt of the metabolite, or a prodrug of the metabolite in a unit dosage form of about 0.0001 milligrams to about 499 milligrams, wherein the doxepin, the salt or the prodrug is a geometric isomer mixture containing about 18.2% to about 100.0% of the cis-(Z) isomer of the metabolite.
89 - 118 . (canceled)